ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise against aggressive esophageal cancer
Disease control CompletedThis study looked at 26 people with a type of esophageal cancer who had a high chance of the cancer coming back after standard treatment (chemotherapy, radiation, and surgery). They received more chemotherapy and radiation plus an immunotherapy drug called pembrolizumab. The goal…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated May 26, 2026 11:49 UTC
-
New pill shows promise against tough cancers in early trial
Disease control CompletedThis early-phase study tested a new daily pill called JAB-3312 in 40 adults with advanced solid tumors (like lung, colorectal, or breast cancer) that had stopped responding to standard treatments. The main goals were to find the safest dose and check for side effects. Researchers…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Artery-Saving surgery may reduce complications after esophageal cancer removal
Disease control CompletedThis study looked at 120 people with esophageal cancer who had a specific type of surgery (McKeown esophagectomy). The goal was to see if keeping the right gastric artery intact, instead of tying it off, would lead to fewer problems like leaks or narrowing where the esophagus is …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: The First Hospital of Hebei Medical University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
AI predicts which esophageal cancer patients are cured by immunotherapy combo
Diagnosis CompletedThis study looked at medical records and CT scans from 363 adults with esophageal cancer who received chemotherapy and immunotherapy before surgery. Researchers developed a computer model that combines patient information, image features, and deep learning to predict whether the …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Nanjing Medical University • Aim: Diagnosis
Last updated May 22, 2026 13:52 UTC
-
New cancer drug SGN-B6A tested for safety in chinese patients
Symptom relief CompletedThis early-stage study tested a new drug called SGN-B6A in 6 Chinese patients with advanced solid tumors (lung, head and neck, esophageal, or stomach cancers). The main goal was to check for side effects and see how the body processes the drug. It was not designed to measure if t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Symptom relief
Last updated May 26, 2026 11:29 UTC
-
Diabetes may worsen cancer surgery outcomes, new study suggests
Knowledge-focused CompletedThis study looked at 605 people with esophageal cancer who had minimally invasive surgery to remove part of their esophagus. Researchers wanted to see if having type 2 diabetes made recovery or long-term survival worse, and whether diabetes medication (metformin) or good blood su…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 11:35 UTC
-
Which feeding tube is best after esophageal cancer surgery?
Knowledge-focused CompletedThis study looked at 577 people who had surgery for esophageal cancer. It compared two ways of giving nutrition after surgery: a feeding tube placed directly into the small intestine (jejunostomy) versus a tube through the nose into the stomach (nasoenteric tube). The goal was to…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC